Subsequently, a positive trend remained for T&E at month 6, whereas the mean VA for PRN-treated eyes gradually declined from month 3 to 12.
← all excerpts
A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom.
1
—
—